Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11084884
APP PUB NO 20170002094A1
SERIAL NO

15113297

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • TAKEDA PHARMACEUTICAL COMPANY LIMITED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adelman, Burt Concord, US 20 90
Biedenkapp, Joseph Newton, US 2 10
Chyung, Yung Lexington, US 13 49
Faucette, Ryan Melrose, US 18 74
Iarrobino, Ryan Sterling, US 3 10
Kenniston, Jon A Hingham, US 13 51
Sexton, Daniel J Melrose, US 57 508
TenHoor, Christopher Hopkinton, US 23 150

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 10, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 10, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 10, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00